-

GE Healthcare Unveils Latest Ultra-Premium Ultrasound in Women’s Health Portfolio

  • Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound
  • Next-generation architecture behind Voluson Expert 22 includes Voluson graphic-based beam former technology; AI powered tools; and customizable touch panel, color and lighting options

CHICAGO--(BUSINESS WIRE)--GE Healthcare today unveiled its most advanced ultrasound yet, the next-generation Voluson™ Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. Cutting-edge tools powered by Artificial Intelligence (AI) ensure greater consistency in exams and decreased number of tasks. Customizable touch panels, color and lighting options provide for a revolutionary user experience.

As pregnancies grow increasingly complex, clinicians are demanding improvements in technology that allow for greater confidence at the point of care. Shrinking workforces are straining healthcare systems around the world, and without intensive training to operate complex medical imaging technology, clinicians are therefore demanding smart, intuitive systems that reduce the burden on individual users.

The Voluson Expert 22’s Lyric Architecture unlocks new imaging and processing power to achieve higher resolution, detailed images—and increased independence from body habitus and other difficult scanning conditions. The Lyric Architecture generates new levels of penetration, resolution, and frame rates to reveal fine anatomy in 2D/3D/4D with ease, and delivers uniformity throughout the image with increased spatial and contrast resolution.

According to Prof. Dr. Rabih Chaoui, Managing Director at the Center for Prenatal Diagnosis and Human Genetics in Berlin, Germany, said: “The Voluson Expert 22 is a masterpiece of engineering with exceptional 2D images from thin to difficult scanning patients. This machine also has the outstanding ergonomics and is the most customizable system ever produced. It is one of the best ultrasound machines I have ever used.”1

Voluson’s modern user interface is simple and seamless, and the 23.8 inch high-definition ultrasound (HDU) display offers 3 image sizes including unique full screen images that allows clinicians to work comfortably and see finer details with ease. Clinicians can personalize the user interface according to their unique preferences and Respond probe activation automatically initializes the probes and presets when removed from the probe holder.

Dr. Lawrence Platt, MD, an Obstetrician-gynecologist at the Center for Fetal Medicine in Los Angeles, USA, commented: “By using AI, we are pushing limits and enhancing diagnostic capabilities. At the same time, the functionality makes exams easier. The AI built into this machine is so far advanced compared to what we've seen before, and it’s only a hint. It's our responsibility to push it even further by using it, by challenging it, and showing it, makes a difference.”1

AI-powered tools include SonoLyst, which helps identify fetal anatomy seen on standard views while enhancing efficiency by up to 65%* by adding annotations and measurements; SonoPelvicFloor, which simplifies the exam process by 80%* automating plane alignment and measurements while offering workflow guidance to improve efficiency while eliminating uncertainty; SonoCNS which supports consistent measurements and help drive workflow efficiency and reduce exam time by 81%* by helping align and display recommended views and measurements of the fetal brain from a 3D Volume.

“Technology continues to move obstetrics and gynecology forward, but there is a delicate balance between using technology to enhance medical care and the human role in medicine” said, Gerald Seifriedsberger, General Manager- Women’s Health. “We are incredibly proud to build on our legacy of innovation in women’s health with the introduction of the Voluson Expert 22, and deliver advanced ultrasound imaging at the point of care that allows for more shared decision-making between clinician and patient.

Designed in partnership with leading OBGYN’s, the intuitive and customizable ultra-premium Voluson Expert 22 is designed for a world where patients want answers earlier, and clinicians need to answer questions with greater confidence.

With GE Healthcare’s Voluson ultrasound systems, clinicians conduct more than 400 million women’s health ultrasound exams every year.

For more information on GE Healthcare’s Voluson Expert 22, visit https://www.gehealthcare.com/products/ultrasound/voluson/voluson-Expert22.

GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

______________________________
1 Statements by GE’s customers are based on their own opinions and on results achieved in the customer’s unique setting. Since there is no ‘typical’ clinical setting and many variables exist (e.g. hospital size, case mix), there can be no guarantee that the customers will achieve the same results. GE Healthcare may have unrelated contractual agreement with Dr. Chaoui and/or Dr. Platt

Contacts

Nader Abou-Guendia
Nader.abou-guendia@ge.com
+97155 980 4206

GE Healthcare

NYSE:GE

Release Versions

Contacts

Nader Abou-Guendia
Nader.abou-guendia@ge.com
+97155 980 4206

More News From GE Healthcare

GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.2 This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision. Studies...

GE HealthCare to showcase AI and digital leadership at HIMSS 2026

LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies...

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™ Sprint with Freelium™1, a 1.5T sealed magnet MRI system; SIGNA™ Bolt2, an advanced 3T MRI scanner; and SIGNA™ One3, an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond. The new MRI systems and technology combat some of the...
Back to Newsroom